2 Firms Guide Eli Lilly's $1.2B Ventyx Biosciences Acquisition

By Al Barbarino · January 8, 2026, 4:17 PM EST

Eli Lilly and Co. has agreed to acquire Ventyx Biosciences Inc., a San Diego-based clinical-stage biopharmaceutical company, for about $1.2 billion in cash, with Ropes & Gray LLP and Wilson Sonsini...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login